Growing evidence has been demonstrated that AGR2 is overexpressed in prostate cancer [2], lung cancer [3], breast cancer [4], and pancreatic cancer [5], and promotes cell proliferation, invasion, and metastasis via multiple mechanisms [4–7]. Here, AGR2 is linked to lung cancer.